Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

TGF-β1 from dermal papilla cells suppresses hair growth, and targeting it may help treat androgenetic alopecia.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

Higher levels of the DP2 receptor may lead to hair loss.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Prolactin contributes to hair loss by promoting hair follicle shrinkage and cell death.

Androgens affect the function and health of the endometrium.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

The gene URB is more active in human hair growth cells and responds to a hair-related hormone.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.